Schizophrenia Research
Volume 91, Issue 1 , Pages 27-36, March 2007

The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland

  • Joni A. Turunen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • These authors contributed equally to this work.
  • ,
  • Juho O. Peltonen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • These authors contributed equally to this work.
  • ,
  • Olli P.H. Pietiläinen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
  • ,
  • William Hennah

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
  • ,
  • Anu Loukola

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
  • ,
  • Tiina Paunio

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Department of Psychiatry, Helsinki University Central Hospital, P.O. Box 590, FI-00029, Helsinki, Finland
    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
  • ,
  • Kaisa Silander

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
  • ,
  • Jesper Ekelund

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
  • ,
  • Teppo Varilo

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02139, MA, USA
  • ,
  • Timo Partonen

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
  • ,
  • Jouko Lönnqvist

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
  • ,
  • Leena Peltonen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • Department of Medical Genetics, University of Helsinki, P.O. Box 63, FI-00014, Helsinki, Finland
    • Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02139, MA, USA
    • Corresponding Author InformationCorresponding author. Department of Molecular Medicine, National Public Health Institute, Biomedicum, Haartmaninkatu 8, FI-00290 Helsinki, Finland. Tel.: +358 9 4744 8393; fax: +358 9 4744 8480.

Received 28 June 2006; received in revised form 26 October 2006; accepted 30 November 2006. published online 14 February 2007.

Abstract 

Several putative schizophrenia susceptibility genes have recently been identified. Significant associations between schizophrenia and neuregulin 1 (NRG1) and dysbindin (DTNBP1) were first reported in 2002 and studies in several populations have since independently reported positive associations to these gene regions. Further, both tentative functional and genetic data have implicated the role of AKT1 in the genetic background of this disorder. However, findings have not been consistent in all populations. We investigated the allelic diversity of these three genes NRG1, DTNBP1 and AKT1 in a representative nation-wide study sample of 441 Finnish schizophrenia families consisting of 865 affected individuals, in order to assess their role in one of the largest population-based study samples. DTNBP1 and AKT1 failed to show evidence of association, whereas two SNPs in the 3′ region of the NRG1 gene yielded suggestive evidence of association (p=0.012 and p=0.048) in family-based association analyses. Thus, our study does not indicate that AKT1 or DTNBP1 play a role in the etiology of schizophrenia in the Finnish population. Furthermore, results do not support a major role for NRG1, but we cannot completely exclude a minor role of this gene in the Finnish population.

Abbreviations: AKT1, V-akt murine thymoma viral oncogene homolog 1, CEPH, The Centre d'Etude du Polymorphisme Humain, DISC1, Disrupted in schizophrenia 1, DSM-IV, The Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition, DTNBP, Dystrobrevin binding protein 1, FBAT, Family based association test, MIM, Mendelian inheritance in man, NRG1, Neuregulin 1, LC, Liability class, LD, Linkage disequilibrium, SNP, Single nucleotide polymorphism

Keywords: NRG1, DTNBP1, AKT1, Schizophrenia, Association, Finland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(06)00502-0

doi:10.1016/j.schres.2006.11.028

Schizophrenia Research
Volume 91, Issue 1 , Pages 27-36, March 2007